XML 143 R53.htm IDEA: XBRL DOCUMENT v3.26.1
Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Schedule of Accrued Expenses and Other Current Liabilities [Abstract]    
Accrued research and development expense $ 1,754,083 $ 1,799,583
Accrued directors and officers (owners) compensation 1,358,293 1,025,867
Cash portion of the Lind Note repayments 492,376 127,759
Accrued compensation and employee benefits 86,744 126,106
Others 470,133 430,107
Total $ 4,161,629 $ 3,509,422